Microorganisms (Nov 2023)

Human PBMCs Form Lipid Droplets in Response to Spike Proteins

  • Kokilavani Sivaraman,
  • Paco Pino,
  • Guillaume Raussin,
  • Stephanie Anchisi,
  • Charles Metayer,
  • Nicolas Dagany,
  • Julia Held,
  • Sabine Wrenger,
  • Tobias Welte,
  • Maria J. Wurm,
  • Florian M. Wurm,
  • Beata Olejnicka,
  • Sabina Janciauskiene

DOI
https://doi.org/10.3390/microorganisms11112683
Journal volume & issue
Vol. 11, no. 11
p. 2683

Abstract

Read online

Intracellular lipid droplets (LDs) can accumulate in response to inflammation, metabolic stresses, and other physiological/pathological processes. Herein, we investigated whether spike proteins of SARS-CoV-2 induce LDs in human peripheral blood mononuclear cells (PBMCs) and in pulmonary microvascular endothelial cells (HPMECs). PBMCs or HPMECs were incubated alone or with endotoxin-free recombinant variants of trimeric spike glycoproteins (Alpha, Beta, Delta, and Omicron, 12 µg/mL). Afterward, cells were stained with Oil Red O for LDs, cytokine release was determined through ELISA, and the gene expression was analyzed through real-time PCR using TaqMan assays. Our data show that spikes induce LDs in PBMCs but not in HPMECs. In line with this, in PBMCs, spike proteins lower the expression of genes involving lipid metabolism and LD formation, such as SREBF1, HMGCS1, LDLR, and CD36. On the other hand, PBMCs exposed to spikes for 6 or 18 h did not increase in IL-1β, IL-6, IL-8, MCP-1, and TNFα release or expression as compared to non-treated controls. Thus, spike-induced LD formation in PBMCs seems to not be related to cell inflammatory activation. Further detailed studies are warranted to investigate in which specific immune cells spikes induce LDs, and what are the pathophysiological mechanisms and consequences of this induction in vivo.

Keywords